Effect of cancer cachexia on the outcomes of first-line chemotherapy in pancreatic cancer: A claims database study

被引：0
|
作者：
Furuse, Junji [1 ]
Osugi, Fumihiko [2 ]
Machii, Koji [2 ]
Niibe, Koji [2 ]
Endo, Toshimitsu [2 ]
机构：
[1] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan
[2] Ono Pharmaceut Co Ltd, Ono, Hokkaido, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.308
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO61-3
引用
收藏
页码：S1435 / S1435
页数：1
相关论文
共 50 条
  • [1] Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan
    Junji Furuse
    Fumihiko Osugi
    Koji Machii
    Koji Niibe
    Toshimitsu Endo
    International Journal of Clinical Oncology, 2024, 29 : 456 - 463
  • [2] Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan
    Furuse, Junji
    Osugi, Fumihiko
    Machii, Koji
    Niibe, Koji
    Endo, Toshimitsu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (04) : 456 - 463
  • [3] Impact of cancer cachexia on survival in patients with pancreatic cancer and the efficacy of first-line chemotherapy
    Nishida, Tsutomu
    Hosokawa, Kana
    Sugimoto, Aya
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (08) : 1204 - 1205
  • [4] A Chinese Retrospective Multicenter Study of First-Line Chemotherapy for Advanced Pancreatic Cancer
    Cui, Hanzhi
    Guan, Jingzhi
    Deng, Guochao
    Yuan, Jiajia
    Lou, Changjie
    Zhang, Wen
    Zhou, Aiping
    Zhang, Yanqiao
    Zhou, Jun
    Dai, Guanghai
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [5] Impact of cachexia on survival before first-line chemotherapy for metastatic breast cancer
    Nozawa, Kazuki
    Isogai, Ayaka
    Takatsuka, Daiki
    Endo, Yuka
    Ozaki, Yuri
    Horisawa, Nanae
    Kataoka, Ayumi
    Kotani, Haruru
    Yoshimura, Akiyo
    Hattori, Masaya
    Sawaki, Masataka
    Iwata, Hiroji
    ANNALS OF ONCOLOGY, 2022, 33 : S491 - S492
  • [6] Negative impact of cachexia during chemotherapy on survival as first-line chemotherapy for metastatic colorectal cancer
    Nozawa, Kazuki
    Masuishi, Toshiki
    Kumanishi, Ryosuke
    Nakazawa, Taiko
    Ogata, Takatsugu
    Matsubara, Yuki
    Kato, Kyoko
    Narita, Yukiya
    Honda, Kazunori
    Bando, Hideaki
    Kadowaki, Shigenori
    Andoh, Masashi
    Tajika, Masahiro
    Muro, Kei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [7] Feasibility study of FOLFIRINOX as first-line chemotherapy for metastatic pancreatic cancer (KOBE FOLFIRINOX study)
    Hatachi, Yukimasa
    Satake, Hironaga
    Kotake, Takeshi
    Ogata, Takatsugu
    Okita, Yoshihiro
    Yasui, Hisateru
    Tsuji, Akihito
    ANNALS OF ONCOLOGY, 2017, 28
  • [8] Outcomes of first-line chemotherapy for visceral crisis in metastatic breast cancer
    Andrade, Matheus de Oliveira
    Felix, Vitor Hugo
    Bonadio, Renata Colombo
    Testa, Laura
    CANCER RESEARCH, 2024, 84 (09)
  • [9] A Multi-center Retrospective Study on First-line Chemotherapy for Advanced Pancreatic Cancer in China
    Cui, H.
    Deng, G.
    Yuan, J.
    Lou, C.
    Zhang, W.
    Zhou, A.
    Zhang, Y.
    Zhou, J.
    Dai, G.
    PANCREAS, 2020, 49 (10) : 1404 - 1404
  • [10] GEMOX as first-line chemotherapy in advanced pancreatic cancer (APC): A monoinstitutional experience
    Di Marco, M.
    Nobili, E.
    Di Cicilia, R.
    Brandi, G.
    Bertolini, S.
    Derenzini, E.
    Dell'Arte, S.
    Casadei, R.
    Calculli, L.
    Biasco, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345